Intracranial Hemorrhage Clinical Trial
Official title:
INVEST: A Single Arm, Feasibility Study of Minimally Invasive Endoscopic Surgical Treatment With Apollo for Supratentorial Intracerebral Hemorrhage (ICH)
The primary objective of this multicenter single arm feasibility study is to provide an assessment of enrollment and follow up feasibility for this patient population being treated with the Apollo Minimally Invasive Surgical Treatment (MIES). Patients who do not qualify for the INVEST Feasibility Study will be referred to the INVEST Registry study.
Objective: The primary objective of this multicenter single arm feasibility study is to provide an assessment of enrollment and follow up feasibility for this patient population being treated with the Apollo or Artemis Minimally Invasive Surgical Treatment (MIES). Patients who do not qualify for the INVEST Feasibility Study will be referred to the INVEST Registry study. Study Design: This study will be a prospective, multi-centered trial that will enroll 50 patients at up to 10 United States (US) centers. Patient Population: Patients with moderate-large volume (20-80 cc) supratentorial intracerebral hemorrhage (ICH) who present within 24 hours of symptom onset. Enrolled patients will receive minimally invasive endoscopic evacuation with the Apollo system or Artemis Device. Indication: The Artemis Neuro Evacuation Device is used for the controlled aspiration of tissue and/or fluid during surgery of the Ventricular System or Cerebrum in conjunction with a Penumbra Aspiration Pump. The Penumbra Aspiration Pump is indicated as a vacuum source for the Penumbra Aspiration Systems. The Apollo system has been cleared for the controlled aspiration of soft tissue and/or fluid during endoscopically guided neurosurgery of the ventricular system or cerebrum. In the present study, the researchers propose to investigate the feasibility of studying this patient population for eventual implementation of efficacy trials. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00795119 -
A Trial to Determine the Efficacy of Near Infrared Spectroscopy to Detect Intracranial Hemorrhage in Children
|
N/A | |
Completed |
NCT04062097 -
Registration of Idarucizumab for Patients With IntraCranial Hemorrhage
|
||
Completed |
NCT02146040 -
Atrial Fibrillation as a Cause of Stroke and Intracranial Hemorrhage Study (The FibStroke Study)
|
||
Completed |
NCT02661672 -
INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain Hemorrhage
|
N/A | |
Terminated |
NCT01463878 -
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
|
Phase 4 | |
Withdrawn |
NCT01042574 -
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
|
Phase 4 | |
Completed |
NCT05517109 -
Hemodynamic in Postreperfusion Period and Functional Recovery in Acute Ischemic Stroke Patients
|
N/A | |
Completed |
NCT01620203 -
Observational Study in Preterm Infants With Intracranial Hemorrhage
|
||
Recruiting |
NCT06096051 -
Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage
|
||
Completed |
NCT01850797 -
Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)
|
N/A | |
Completed |
NCT01115660 -
Stroke Education Intervention Trial - Pilot
|
N/A | |
Completed |
NCT00413946 -
Does Erythropoietin Improve Outcome in Very Preterm Infants?
|
Phase 2 | |
Recruiting |
NCT00505505 -
Intensive Insulin Therapy for Strict Glycemic Control in Neurosurgical Patients: Safety and Efficacy
|
Phase 4 | |
Withdrawn |
NCT05075486 -
Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support
|
N/A | |
Recruiting |
NCT05361070 -
Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy
|
||
Completed |
NCT04839770 -
MIECH: The Minimally Invasive Endoscopic Surgery With the Axonpen System for Spontaneous Intracerebral Hemorrhage
|
N/A | |
Completed |
NCT02809651 -
Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner
|
N/A | |
Recruiting |
NCT04819451 -
Application of Magnesium-rich Artificial Cerebrospinal Fluid in Subarachnoid Hemorrhage
|
N/A | |
Terminated |
NCT00770718 -
Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage
|
Phase 1 |